Search
for
Sort by
Research 421–450 of 1000+
- Repurposing existing drugs for COVID-19: an endocrinology perspective
- Unraveling Ritlecitinib: an in-depth analysis of JAK3 inhibitor for the treatment of alopecia areata
- 153 Effectiveness of OR-101, a next generation highly selective JAK3 inhibitor, in a humanized murine model of alopecia areata
- Tyrosine kinase Inhibitors in Dermatology: A Systemic Review
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib
- Discovery of a novel and highly selective JAK3 inhibitor as a potent hair growth promoter
- The Use of Janus Kinase Inhibitors for Primary Neutrophilic Cicatricial Alopecias
- Epigallocatechin-3-gallate inhibits paclitaxel-induced apoptosis through the alteration of microRNA expression in human dermal papilla cells
- In Silico Structure-Based Drug Design Approach To Evaluate Quercetin And Kaempferol As Dual Inhibitors Of Jak3 Kinase And 5-Alpha Reductase Type II with ADMET Profiling
- In Silico Structure-Based Drug Design Approach To Evaluate Quercetin And Kaempferol As Dual Inhibitors Of Jak3 Kinase And 5-Alpha Reductase Type II with ADMET Profiling
- Dual improvement of alopecia areata and immune thrombocytopenia with baricitinib: a case report
- 290 Brepocitinib improves cicatricial alopecia and downregulates key T-helper biomarkers
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- JAK1 gain-of-function variant causes alopecia areata, atopic dermatitis, and autoimmune thyroid disease
- 802 Molecular effect of brepocitinib in hidradenitis suppurativa (HS)
- Baricitinib in the Management of Coexisting Alopecia Areata and Atopic Dermatitis: A Case Report
- Application of Baricitinib in Dermatology
- 0480 Upadacitinib monotherapy for treatment of pyoderma gangrenosum: A case series
- Androgenetik Alopesi
- The common regulatory pathway of COVID-19 and multiple inflammatory diseases and the molecular mechanism of cepharanthine in the treatment of COVID-19
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Upadacitinib: A New Weapon for the Treatment of Twenty-Nail Dystrophy
- Effective treatment of refractory alopecia areata in pediatric patients with oral abrocitinib
- Tofacitinib Treatment in Patients With Active COVID-19 Infection
- Rapid hair regrowth in an alopecia universalis patient with deucravacitinib: A case report
- Review of Promising Off-Label Use of Deucravacitinib
- Abrocitinib in the Treatment of Severe Alopecia Areata in a Pediatric Patient: A Case Report
- Unique Circulating MicroRNA Signatures Distinguish Severe Alopecia Areata from Other Inflammatory Skin Diseases
- Could baricitinib treat frontal fibrosing alopecia and facial papules?
- The Pathogenesis and Treatment Progress of Androgenic Alopecia